Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
13.63
-0.73 (-5.05%)
Apr 10, 2025, 1:37 PM EDT - Market open
Travere Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$33.25
Upside
+144.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $45 → $47 | Strong Buy | Maintains | $45 → $47 | +244.95% | Apr 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 3, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $29 → $31 | Strong Buy | Maintains | $29 → $31 | +127.52% | Apr 1, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $42 → $44 | Buy | Maintains | $42 → $44 | +222.94% | Feb 26, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $31 → $35 | Strong Buy | Maintains | $31 → $35 | +156.88% | Feb 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Feb 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $27 → $32 | Buy | Maintains | $27 → $32 | +134.86% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $33 → $45 | Buy | Maintains | $33 → $45 | +230.28% | Feb 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $22 → $45 | Strong Buy | Maintains | $22 → $45 | +230.28% | Feb 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $22 | Strong Buy | Maintains | $18 → $22 | +61.47% | Jan 15, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $22 | Hold | Maintains | $12 → $22 | +61.47% | Nov 14, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $23 → $27 | Buy | Maintains | $23 → $27 | +98.17% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +46.79% | Nov 1, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $9 → $27 | Hold → Buy | Upgrades | $9 → $27 | +98.17% | Oct 21, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $23 | Buy | Initiates | $23 | +68.81% | Oct 16, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $20 → $40 | Buy | Maintains | $20 → $40 | +193.58% | Oct 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.